Rheumatology Network's November 2022 Recap

Symptom-Targeting Non-Pharmacological Approaches Individualize Fibromyalgia Treatment

Personalizing non-pharmacological treatment for patients with fibromyalgia using a targeted symptom approach may improve outcomes.

Early Gout Onset, Tophaceous Disease in Men Linked to Risk Alleles

"It may be important to identify genetic variants from a gout genome-wide association study (GWAS) rather than serum urate GWAS, in case these variants have an effect on gout independent of their effect on serum urate.”

ACR 22 Convergence Preview, with Zsuzsanna McMahan, MD

Each year, the American College of Rheumatology (ACR) hosts an annual meeting that serves as one of the foremost opportunities for advancement and collaboration within the field of rheumatology. This year’s meeting, aptly named ACR 2022 Convergence, represents the first opportunity for many within the field to converge, collaborate, and celebrate the advances within the field together since 2019.

COVID-19 Negatively Impacts Physical Activity in Patients with Rheumatic Disease

Investigators aimed to assess self-reported changes in physical activity during the COVID-19 pandemic.

Inflammatory Arthritis: Trends, Risk Factors, and What Rheumatologists Need to Know

Rheumatology Network interviewed Bahar Moghaddam, MD, Assistant Professor of Medicine in the Division of Rheumatology, Mount Sinai Health System, to discuss the impact of arthritis in the United States and worldwide, recent drug approvals, and the importance of early diagnosis and management of rheumatic diseases. Refresh your knowledge of arthritis with this professional insight.